Isernia Sara, Pagliari Chiara, Morici Nuccia, Toccafondi Anastasia, Banfi Paolo Innocente, Rossetto Federica, Borgnis Francesca, Tavanelli Monica, Brambilla Lorenzo, Baglio Francesca
IRCCS Fondazione Don Carlo Gnocchi ONLUS, 20148 Milan, Italy.
IRCCS Fondazione Don Carlo Gnocchi ONLUS, 50143 Florence, Italy.
J Clin Med. 2022 Dec 21;12(1):64. doi: 10.3390/jcm12010064.
Telerehabilitation (TR) for chronic heart failure (CHF) allows for overcoming distance barriers and reducing exacerbations. However, little is known about TR descriptors, components, and efficacy in CHF.
This work systematically reviewed the TR strategies of randomized controlled trials in people with CHF. A meta-analysis was run to test its effect on exercise capacity and quality of life compared to no rehabilitation (NI) and conventional intervention (CI).
Out of 6168 studies, 11 were eligible for the systematic review, and 8 for the meta-analysis. TR intervention was individual and multidimensional, with a frequency varying from 2 to 5 times per 8-12 weeks. The TR components mainly included an asynchronous model, monitoring/assessment, decision, and offline feedback. A few studies provided a comprehensive technological kit. Minimal adverse events and high adherence were reported. A large effect of TR compared to NI and a non-inferiority effect compared to CI was registered on exercise capacity, but no effects of TR compared to NI and CI on quality of life were observed.
TR for people with CHF adopted established effective strategies. Future interventions may identify the precise TR dose for CHF, technological requirements, and engagement components affecting the patient's quality of life.
慢性心力衰竭(CHF)的远程康复(TR)能够克服距离障碍并减少病情加重。然而,关于CHF的TR描述符、组成部分和疗效知之甚少。
本研究系统回顾了CHF患者随机对照试验的TR策略。进行荟萃分析以测试其与无康复治疗(NI)和传统干预(CI)相比对运动能力和生活质量的影响。
在6168项研究中,11项符合系统评价的标准,8项符合荟萃分析的标准。TR干预是个体化且多维度的,频率为每8 - 12周2至5次。TR的组成部分主要包括异步模式、监测/评估、决策和离线反馈。少数研究提供了全面的技术套件。报告的不良事件极少且依从性高。与NI相比,TR对运动能力有显著影响,与CI相比有非劣效性影响,但与NI和CI相比,TR对生活质量没有影响。
CHF患者的TR采用了既定的有效策略。未来的干预措施可能会确定CHF的精确TR剂量、技术要求以及影响患者生活质量的参与因素。